NCI Center for Cancer Research’s Post

🎉 Last week, we celebrated the incredible career of Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch. Hundreds of attendees both in-person and online came together to honor his pioneering in the development of effective immunotherapies for patients with advanced cancer. Former and current colleagues, trainees and patients were able to thank Dr. Rosenberg for his impact on the field and discuss the optimism they have for the future of cancer research because of his work.    Thank you to the Center for Excellence in Immunology for sponsoring, the organizers and to everyone who participated in this incredible symposium. 👏 Share your favorite photo if you attended or a memory you have with Dr. Rosenberg in the comments! National Cancer Institute (NCI), NIH Clinical Center (CC), The National Institutes of Health

📣 NOW ENROLLING: Nicholas D. Klemen, M.D., Physician-Scientist Early Investigator in the Surgery Branch, is researching drug therapy for adults with colorectal or gastroesophageal cancer.    Are you a physician with a patient you want to refer? Contact the NCI Cancer Information Service for more information and provide the trial ID: NCT06410534. 👉 https://lnkd.in/ehSsPvbM National Cancer Institute (NCI), NIH Clinical Center (CC)

👏 Our Center for Cancer Research Principal Investigators gathered with NCI Cancer Epidemiology and Genetics Principal Investigators for our annual retreat earlier this week. They had the opportunity to hear from and present the following awards to outstanding external speakers: ⭐ On the top left, Kevan Shokat, Ph.D., of University of California, San Francisco, was presented with the 27th Annual Alfred G. Knudson Award by Deborah Morrison, Ph.D., Chief of CCR's Laboratory of Cell and Developmental Signaling. ⭐ On the top right, Julie Buring, Sc.D., of Harvard Medical School and Brigham and Women's Hospital, was presented with the 21st Annual NCI Rosalind E. Franklin Award by Meredith Shiels, Ph.D., Senior Investigator in DCEG's Infections and Immunoepidemiology Branch. ⭐ On the bottom, investigators discussed their work in a poster session. National Cancer Institute (NCI), National Institutes of Health (NIH): Intramural Research Program (IRP)

📹 WATCH: Dr. Cecilia Monge is a physician in our Liver Cancer Program here at the National Cancer Institute (NCI) Center for Cancer Research. In this video, Dr. Monge talks about what patients can expect when they become involved in a clinical trial. "We are experts in liver cancer and understand how difficult this journey can be. Our team of renowned researchers and medical professionals is dedicated to developing innovative therapies that will improve patient outcomes." NIH Clinical Center (CC), National Institutes of Health (NIH): Intramural Research Program (IRP), Cecilia Monge B.,MD,MPH,FACP

🌟 As National Hispanic Heritage Month wraps up, Timothy Watts, M.P.H., Diversity and Inclusion Specialist, reflects on his time as a Health Educator for California’s Department of Health Care Services. His work delivering breast and cervical cancer education to Hispanic/Latine and Indigenous communities offered invaluable insights into the importance of culturally tailored health education. These lessons are reflected in CCR’s initiatives, such as its commitment to reducing barriers to clinical trial participation and increasing access for communities that have historically faced challenges in contributing to cancer research. 📖 Read more about these reflections and insights: https://lnkd.in/dRhwVPS6 Let’s continue to celebrate and uplift the contributions of Hispanic/Latine communities in advancing health equity! 👏 National Cancer Institute (NCI), The National Institutes of Health, National Institutes of Health (NIH): Intramural Research Program (IRP)

📹 WATCH: Here at the National Cancer Institute (NCI) Center for Cancer Research, our highly trained physicians develop and conduct a wide range of clinical trials in a quest to develop the medicines of tomorrow for patients with cancer, HIV or immunodeficiency disorders. All of our trials take place at the NIH Clinical Center (CC) in Bethesda, MD, the world's largest research hospital, and through telehealth. Want to learn more? Visit our website and click on the 'Clinical Trials' tab, as shown in the video below! 👇 https://lnkd.in/evVahmbe

🗓 UPCOMING EVENT: Our Cancer Moonshot programs at the National Cancer Institute and Center for Cancer Research, NCI-CONNECT and MyPART, are co-hosting an educational webinar to continue to bring awareness to gaps and opportunities for collaboration in care for adolescents and young adults (AYA) with central nervous system (CNS) tumors. The co-chairs include senior clinicians, Dr. Marta Penas-Prado (NCI-CONNECT, Neuro-Oncology Branch) and Dr. John Glod (MyPART, Pediatric Oncology Branch), and chief and senior investigator, Dr. Brigitte Widemann (MyPART, Pediatric Oncology Branch). Our Acting Co-director, Dr. James Gulley, will provide opening remarks. The webinar will have expert speakers to address what we know about CNS tumors in AYAs—prevalence, incidence and survival data—the molecular differences across the age spectrum, unmet needs in clinical care and clinical trial access, and support and survivorship topics like psychological support, symptom management, and onco-fertility. The webinar on October 30, starting at 11 a.m. ET, is free and open to the public. We encourage health care professionals, patients, caregivers, and advocates to attend. Register: https://go.nih.gov/nQcX4We